EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Research Advances in Nucleic Acid Delivery System for Rheumatoid Arthritis Therapy

Xintong Zhang iD, Yanhong Liu, Congcong Xiao, Youyan Guan, Zhonggao Gao, Wei Huang

Pharmaceutics · 13.04.2023 · 15 (4) · 1237

DOI: 10.3390/pharmaceutics15041237 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 13.04.2023. Verfasst von Xintong Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and P…. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, CAMS Innovation Fund for Medical Sciences (CIFMS, China), Bethune Urinary Cancer Special Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease that affects the lives of nearly 1% of the total population worldwide. With the understanding of RA, more and more therapeutic drugs have been developed. However, lots of them possess severe side effects, and gene therapy may be a potential method for RA treatment. A nanoparticle delivery system is vital for gene therapy, as it can keep the nucleic acids stable and enhance the efficiency of transfection in vivo. With the development of materials science, pharmaceutics and pathology, more novel nanomaterials and intelligent strategies are applied to better and safer gene therapy for RA. In this review, we first summarized the existing nanomaterials and active targeting ligands used for RA gene therapy. Then, we introduced various gene delivery systems for RA treatment, which may enlighten the relevant research in the future.

Schlagwörter

Stichwörter der Autor:innen

gene therapynanomaterialsnon-viral vectorsnucleic acid delivery systemrheumatoid arthritis

Autor:innen und Institutionen

  • State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
  • Beijing Key Laboratory of Drug Delivery Technology and Novel Formulations, Department of Pharmaceutics, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050,…
  • Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.

ORCID-Profile: Xintong Zhang

Förderung

  • National Natural Science Foundation of China
  • CAMS Innovation Fund for Medical Sciences (CIFMS, China)
  • Bethune Urinary Cancer Special Research Fund
  • CSCO Navigation Cancer Research Fund

Zitieren

APA

Zhang, X., Liu, Y., Xiao, C., Guan, Y., Gao, Z., & Huang, W. (2023). Research Advances in Nucleic Acid Delivery System for Rheumatoid Arthritis Therapy. Pharmaceutics, 15(4), 1237. https://doi.org/10.3390/pharmaceutics15041237

Vancouver

Zhang X, Liu Y, Xiao C, Guan Y, Gao Z, Huang W. Research Advances in Nucleic Acid Delivery System for Rheumatoid Arthritis Therapy. Pharmaceutics. 2023;15(4):1237. doi:10.3390/pharmaceutics15041237

BibTeX
@article{Zhang2023,
  author = {Zhang, Xintong and Liu, Yanhong and Xiao, Congcong and Guan, Youyan and Gao, Zhonggao and Huang, Wei},
  title = {Research Advances in Nucleic Acid Delivery System for Rheumatoid Arthritis Therapy},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {4},
  pages = {1237},
  doi = {10.3390/pharmaceutics15041237}
}
Kostenlos starten →